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A Small Ubiquitin-Related Polypeptide
Involved in Targeting RanGAP1
to Nuclear Pore Complex Protein RanBP2
Rohit Mahajan, Christian Delphin, Tinglu Guan, is nuclear protein import (Melchior et al., 1993a; Moore
and Blobel, 1993). Like all Ras-related GTPases, RanLarry Gerace, and Frauke Melchior
operates as a molecular switch by cycling between GTPDepartment of Cell Biology
and GDP bound conformations. Interconversion be-The Scripps Research Institute
tween these two states is regulated by guanine nucleo-10550 North Torrey Pines Rd
tide exchange proteins (GEPs), which stimulate ex-La Jolla, California 92037
change of GDP for GTP, and GTPase-activating proteins
(GAPs), which activate GTP hydrolysis (Bourne et al.,
1990). Both a Ran GEP, the RCC1 protein (Ohtsubo etSummary
al., 1987; Bischoff and Ponstingl, 1991), and a Ran GAP,
RanGAP1 (Bischoff et al., 1994, 1995a), have been identi-We have found that the mammalian Ran GTPase–
fied. At least most of the detectable GEP and GAP activ-activating protein RanGAP1 is highly concentrated at
ity for Ran in cell extracts can be attributed to RCC1the cytoplasmic periphery of thenuclear pore complex
and RanGAP1, respectively (Bischoff et al., 1994; Dasso(NPC), where it associates with the 358-kDa Ran–GTP-
et al., 1994). Ran can engage in nucleotide-specific inter-binding protein RanBP2. This interaction requires the
actions with several cytosolic factors and NPC proteins
ATP-dependent posttranslational conjugation of Ran-
implicated in nuclear transport. Ran-GDP preferentially
GAP1 with SUMO-1 (for small ubiquitin-related modi- binds NTF2 (Nehrbass and Blobel, 1996; Paschal et al.,
fier), a novel protein of 101 amino acids that contains 1996). Ran-GTP specifically interacts with the soluble
low but significant homology to ubiquitin. SUMO-1 ap- components RanBP1 (Bischoff et al., 1995b) and p97
pears to represent the prototype for a novel family of (Rexach and Blobel, 1995; Paschal et al., 1996), and
ubiquitin-related protein modifiers. Inhibition of nu- the NPC protein RanBP2/Nup358 (Wu et al., 1995;
clear protein import resulting from antibodies directed Yokoyama et al., 1995). RanBP1 stimulates RanGAP1-
at NPC-associated RanGAP1 cannot be overcome by induced GTP hydrolysis by Ran (Bischoff et al., 1995b),
soluble cytosolic RanGAP1, indicating that GTP hydro- while yeast p97 (importin b/karyopherin b) inhibits Ran-
lysis by Ran at RanBP2 is required for nuclear protein GAP activity (Floer and Blobel, 1996). How these various
import. interactions are linked to different nuclear transport
steps is still unclear. While it is widely accepted that
GTP hydrolysis by Ran is required for nuclear import,Introduction
several different models involving one or multiple rounds
of GTP hydrolysis by Ran in various regions of the NPCImport of protein into the nucleus is a complex multistep
have been proposed (Melchior et al., 1995a; Rexach andprocess that coordinates nuclear and cytoplasmic func-
Blobel, 1995; Nehrbass and Blobel, 1996; Go¨rlich andtions. Transport is mediated by nuclear pore complexes
Mattaj, 1996).(NPCs), elaborate supramolecular structures that span
To distinguish among these models, we decided tothe nuclear envelope (NE) (reviewed by Rout and Wente,
analyze the localization of RanGAP1 (the only known1994; Bastos et al., 1995; Pante´ and Aebi, 1996a). Al-
GAP for Ran in mammalian cells), because any sitethough some small proteins (<40 kDa) and metabolites
where GTP hydrolysis by Ran occurs should be charac-can diffuse passively through aqueous channels in the
terized by the presence of a RanGAP. RanGAP activityNPC, most proteins are transported by signal- and
has been found both in cytosolic and in nuclear fractionsenergy-dependent mechanisms. Mediated import of
of HeLa cells, but immunolocalization of the 64-kDaproteins containing nuclear localization signals (NLSs)
mammalian RanGAP1 has not been reported as far asis proposed to involve binding of transport substrates to
we know (Bischoff et al., 1994). RanGAP1 is related in
cytoplasmic fibrils of the NPC, movement to the central
sequence to the Saccharomyces cerevisiae and Schizo-
NPC region, and translocation through a central gated
saccharomyces pombe RanGAP Rna1p (Bischoff et al.,
channel to the nuclear interior (reviewed by Melchior 1995a; Becker et al., 1995; Figure 1A), which is localized
and Gerace, 1995; Go¨rlich and Mattaj, 1996; Pante´ and predominantly in the cytoplasm, although a small frac-
Aebi, 1996b). However, most molecular details of these tion might also be present at the NE (Hopper et al., 1990;
transport steps are not understood. Melchior et al., 1993b). Strong evidence for a role of the
Analysis of nuclear protein import in vitro has led to S. cerevisiae RanGAP Rna1p in nuclear import comes
the identification of five conserved soluble factors in- from in vitro assays using the temperature-sensitive S.
volved in this process: the NLS receptor (importin a, cerevisiae strain rna1-1 (Corbett et al., 1995). Therefore
karyopherin a, Srp1p), p97 (importin b, karyopherin b, it seemed likely that mammalian RanGAP1 might also
Kap95), hsp/hsc70, NTF2 (p10, pp15), and the small Ras- be involved in nuclear protein import.
like GTPase Ran (for review, see Sweet and Gerace, We find that RanGAP1 is highly concentrated at the
1995). In addition, at least one other GTPase appears cytoplasmic periphery of the NPC, where it forms a sta-
to be involved in nuclear import (Sweet and Gerace, ble complex with RanBP2. The interaction of RanGAP1
1996). with RanBP2 involves a covalent conjugation of Ran-
The GTPase Ran has been implicated in a variety of GAP1 with a novel 101-residue ubiquitin-related poly-
cellular processes (reviewed by Sazer, 1996), but up to peptide. Antibody treatment of NPC-associated Ran-
GAP1 leads to an inhibition of nuclear protein import thatnow the only pathway to which ithas been directly linked
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yeasts are approximately 30% identical over a shared
domain consisting of eight leucine-rich repeats followed
by a highly acidic stretch (Figure 1A). Whether mamma-
lian RanGAP1, which contains an additional C-terminal
extension (Figure 1A, tail), was a true functional homolog
of Rna1p remained to be established.
To analyze a possible role of mammalian RanGAP1 in
nuclear protein import, we prepared two affinity-purified
antibodies: one directed against full-length RanGAP1,
and one directed against the mammalian-specific tail
domain. We first investigated their effect on RanGAP1-
induced GTP hydrolysis by Ran (Figure 1B, left). Addition
of 100 mg/ml aGAP-tail antibodies had no measurable
effect on RanGAP-stimulated GTP hydrolysis. In con-
trast, addition of only 20 mg/ml aRanGAP1 antibodies
completely abolished RanGAP-induced hydrolysis (Fig-
ure 1B, GAP 1 aRanGAP). We then measured the effect
of these antibodies on nuclear import. aRanGAP1 anti-
bodies strongly inhibited in vitro nuclear import in HeLa
cells (Figure 1B, right), with maximal inhibition (>90%)
at 0.4 mg/ml antibody. This inhibition could be reversed
by the addition of excess recombinant RanGAP1 prior
to antibody addition (see Figure 7). While the maximal
level of inhibition varied somewhat from experiment to
experiment, we routinely obtained >70% inhibition. In
contrast, aGAP-tail antibodies had a much weaker inhib-
itory effect on import (Figure 1B, right). The differential
effects of these two antibodies on RanGAP1-stimulatedFigure 1. Characterization of Antibodies against Full-Length Ran-
GAP1 and against the C-Terminal Domain of RanGAP1 GTP hydrolysis by Ran correlated well with theirdifferen-
(A) Structural motifs of the RanGAP1 protein. The schematic repre- tial effects in inhibition of nuclear protein import, sug-
sentation is based on a sequence comparison among human Ran- gesting that the decrease in transport was at least partly
GAP1 (Bischoff et al., 1995a), its mouse homolog Fug1 (DeGregori mediated by inhibition of RanGAP activity. Taken to-
et al., 1994), S. cerevisiae Rna1p (Traglia et al., 1989), and S. pombe
gether, these data demonstrate that mammalian Ran-rna1p (Melchior et al., 1993b). All proteins contain eight leucine-rich
GAP1 is required for nuclear protein import.repeats and a highly acidic stretch, while the C-terminal tail domain
of 185 amino acids is specific to mammalian RanGAP1.
(B) Antibodies to RanGAP1 inhibit RanGAP1-induced GTP hydroly- Antibodies to RanGAP1 Recognize Two Proteins
sis by Ran as well as in vitro nuclear import. Left: RanGAP1 (1 mg/ with Apparent Molecular Masses
ml)–stimulated GTP hydrolysis by Ran was measured in the absence of 70 kDa and 90 kDa
(GAP only) or presence of 20 mg/ml antibodies raised against full-
Biochemical fractionation of HeLa cells has raised thelength RanGAP1 (GAP plus aRanGAP) or 100 mg/ml antibodies
possibility that mammalian cells may contain severalraised against the C-terminal tail domain (GAP plus aGAP-tail). No
related RanGAP proteins (Bischoff et al., 1994). We in-GAP: endogeneous hydrolysis rate of Ran-GTP in the absence of
RanGAP1. Right: in vitro nuclear protein import was measured in vestigated this question by performing Western blot
the presence of increasing concentrations of aRanGAP1 or aGAP- analysis of several cell extracts (see Figure 1C). Interest-
tail antibodies. ingly, both aRanGAP1 and aGAP-tail antibodies consis-
(C) Antibodies to RanGAP1 reveal both the 70-kDa and the 90-kDa
tently recognized two proteins: one with an apparentRanGAP1-related proteins in several cell extracts. Samples resolved
molecular massof 70 kDathat comigrated with recombi-on an 8% SDS gel were immunoblotted with aRanGAP1 or aGAP-
nant mouse RanGAP1, and one that migrated at an ap-tail antibodies. RanGAP, 3 ng of recombinant RanGAP1. Cell ex-
tracts from HeLa, NRK, and NIH 3T3 tissue culture cells were pre- parent molecular mass of 90 kDa. The staining pattern
pared by lysis of cells in boiling SDS gel–loading buffer, whereas obtained with both antibodies was virtually identical
rat liver extract was prepared by homogenization of rat liver in a (Figure 1C), suggesting that the 70-kDa and 90-kDa
physiological buffer prior to addition of 23 SDS gel loading buffer.
bands are both related to RanGAP1. The ratio of the
two bands was dependent on the method of sample
cannot be overcome by addition of soluble RanGAP1. preparation. When tissue culture cells were scraped di-
These findings suggest that GTP hydrolysis by Ran oc- rectly into boiling SDS–polyacrylamide gel electrophore-
curs at RanBP2 during nuclear protein import. sis (PAGE) loading buffer, both bands were present in
approximately equal abundance (Figure 1C). In contrast,
Results when rat liver (Figure 1C) or HeLa cells (data not shown)
were lysed under nondenaturing conditions prior to ad-
Mammalian RanGAP1 Is Involved in Nuclear dition of SDS, the 90-kDa band predominated.
Protein Import
Rna1p, the only identified S. cerevisiae RanGAP, is re- The 90-kDa RanGAP1-Related Protein
quired for nuclear protein import (Corbett et al., 1995). Is Highly Enriched in NEs
The 64-kDa mammalian RanGAP1 (Bischoff et al.,1995a) To characterize further the 90-kDa RanGAP-like protein,
we analyzed its subcellular distribution by fractionationand the 44-kDa Rna1 proteins from fission and baker’s
Ubiquitin-Related Modification of RanGAP1
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Figure 2. Purification of the 70 kDa and 90
kDa RanGAP1-Related Proteins from Rat
Liver NEs
(A) The 90-kDa RanGAP1-related protein is
highly enriched in rat liver NEs. Equivalent
amounts of subcellular fractions of rat liver
were resolved on an 8% SDS gel and immu-
noblotted with aRanGAP1 antibodies. Total
was taken after homogenization of rat liver.
P1 and SN1, pellet and supernatant of the
first low speed centrifugation; Nuclei,purified
nuclei;DNase Sup,the supernatant of the first
DNase/RNase digest of the nuclei; NEs, the
final NE fraction. NE proteins were enriched
z250-fold. Note that under these conditions,
the 90-kDa protein is the only aRanGAP1-
reactive species detected.
(B) Appearance of the 70-kDa aRanGAP1-
reactive species upon salt extraction of the NE fraction. NEs containing the 90-kDa protein were incubated with 500 mM NaCl and centrifuged,
and the supernatant (Sup) and pellet (Pellet) were analyzed by Western blotting.
(C) Immunoprecipitation with aRanGAP1 antibodies from solubilized rat liver NEs. NEs were solubilized and incubated overnight with aRanGAP1
antibodies preadsorbed to Protein A beads. Antibody–antigen complexes and the remaining supernatant were separated on 8% gels and
either stained with Coomassie blue or immunoblotted with aGAP-tail antibodies. The lower band (z32 kDa) results from a nonspecific interaction
with the Protein A beads (see Figure 6). Asterisk, IgG heavy chain.
of rat liver homogenates (Figure 2A). Whereas a fraction This suggested that the 90-kDa protein might represent
an alternatively spliced form of the previously identifiedof the protein was present in the low speed supernatant
(and remained in a subsequent high speed supernatant; 70-kDa RanGAP1, or an SDS–PAGE-resistant protein
complex of the 70-kDa RanGAP1 with another protein.data not shown), the majority of the protein was present
in the nuclear fraction. DNase/RNase digestion of nuclei,
which releases most nuclear contents, did not solubilize
Identification of a Novel Ubiquitin-Related Proteina significant amount of the 90-kDa protein, indicating
The peptide sequences obtained from the 90-kDa-spe-that a major fraction of the 90-kDa protein is associated
cific HPLC peaks (Table 1, P2–P4) were used to searchwith the NE. Extraction of NEs with high salt resulted in
for related sequences in the DNA databases. While nothe appearance of a 70-kDa band in addition to the
homology to known protein sequences was found, 30expected 90-kDa band (Figure 2B). About 50% of the
overlapping expressed sequence tag (EST) cDNAs from90-kDa band remained in the pellet after salt extraction,
the Human cDNA Database were identified that encodedbut the 70-kDa band was specifically enriched in the
all three peptides. The three longest of these clonessupernatant (Figure 2B; compare supernatant with pel-
were sequenced and found to contain the same putativelet). The appearance of the 70-kDa protein suggested
open reading frame (ORF) of 101 amino acids that in-that this species might derive from the 90-kDa protein by
cluded the three unique peptide sequences present inproteolysis or by loss of a hypothetical posttranslational
the 90-kDa RanGAP protein. The cDNA sequence andmodification.
the deduced protein sequence of the ORF are shown
in Figure 3A. The small calculated size of the proteinThe 90-kDa RanGAP1-Related Protein
(11.5 kDa) suggested that the protein could be post-Contains a Domain Absent from the
translationally coupled to RanGAP1 to yield the 90-kDaRecombinant 70-kDa RanGAP1
species. However, since the cDNAs contained no up-To investigate the relationship between the 90- and
stream stop codons, it was formally possible that this70-kDa protein bands, we solubilized rat liver NEs in
sequence represented an ORF downstream of the origi-radioimmunoprecipitation assay (RIPA) buffer, immuno-
nal published RanGAP1 mRNA sequence, and that aprecipitated the two bands with aRanGAP1 antibodies
hypothetical 59 section encoding a RanGAP1-related(Figure 2C), and analyzed tryptic digests of the two spe-
cies on a C18 high pressure liquid chromatography
(HPLC) column. While the HPLC profiles of tryptic di-
Table 1. Amino Acid Sequences of Tryptic Peptides Derivedgests from the 70- and 90-kDa protein were virtually
from the 70-kDa and 90-kDa Proteinsidentical to each other (data not shown), the profile of
Peptide Sequence 70 kDa 90 kDathe 90-kDa species contained a few peaks missing
from the profile of the 70-kDa species. Several frac- P1 VINLNDNTFTEK 1 1
tions from the HPLC column profiles were selected for P2 ELGMEEEDVIEVY 2 1
peptide sequencing (Table 1). A peptide from the 90- P3 FLFEGQR 2 1
P4 VIGQDSSEIHFK 2 1kDa digest that was common to both species yielded a
sequence found in the published RanGAP1 sequence The 70-kDa and 90-kDa RanGAP proteins obtained by immunopre-
(Table 1, P1), confirming that the 90-kDa protein is cipitation from solubilized NEswere separated by SDS–PAGE, trans-
ferred onto polyvinyldifluoride membrane, and subjected to micro-closely related to RanGAP1. Sequencing of three HPLC
sequencing (Paschal and Gerace, 1995). P1 is present in bothpeaks (Table 1, P2–P4) specific to the 90-kDa protein
proteins as well as in the published sequence of human RanGAP1;demonstrated that none of these sequences was pres-
P2–P4 are specific for the 90-kDA protein.
ent in, or related to, the published RanGAP1 sequence.
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Figure 3. A Novel Ubiquitin-Related Protein (SUMO-1) Contains Peptide Sequence Present in the 90-kDa RanGAP1
(A) cDNA sequence and deduced amino acid sequence of SUMO-1. The ORF codes for a protein of 101 amino acids with a predicted molecular
mass of 11.5 kDa. The three unique peptides detected in the 90-kDa RanGAP protein are present in the ORF (underlined; see also Table 1).
(B) Northern blot analysis of RanGAP1 and SUMO-1 mRNAs. Hela total RNA (20 mg) was separated on a formaldehyde gel, transferred onto
nitrocellulose, and probed with 32P-labeled DNA fragments of RanGAP1 or SUMO-1.
(C) SUMO-1 is a member of a ubiquitin-related protein family. The BLAST search algorithm was used to identify proteins homologous to
SUMO-1. The following proteins were aligned: the deduced protein sequence of a partially sequenced rat EST cDNA clone that is virtually
identical to human SUMO-1 (Rat SUMO-1, EST108203); human and S. cerevisiae SMT3; ubiquitins from human, Dictyostelium discoideum,
S. cerevisiae, and Arabidopsis thaliana; and Nedd-8 from mouse. Dark shading, residues in rat SUMO-1 and the SMT3 proteins that are
identical to corresponding positions of human SUMO-1. Light shading, residues in ubiquitins and Nedd-8 that are identical to human ubiquitin.
Box, residues identical among human and rat SUMO-1 and ubiquitins. Asterisks, residues identical in all proteins compared. Consensus
sequence below is defined by residues that are either identical or highly homologous among members of the SUMO-1, SMT3, and ubiquitin
families.
sequence was missing from all the EST clones. This sequenced EST cDNA encoding a nearly identical pro-
tein from rat) shows 18% identity to ubiquitin. Our data-possibility was addressed by Northern blot analysis of
total HeLa RNA with a 1.1 kb fragment of RanGAP1 base search revealed three additional proteins related
both to the 11.5-kDa protein and to ubiquitin: the ubiqui-cDNA and a 430 bp fragment of the ESTclones, including
the entire ORF (Figure 3B). As reported previously for tin-like mouse protein Nedd8, of unknown function (Ku-
mar et al., 1993), with 58% identity to ubiquitin and 20%mouse RanGAP1 (DeGregori et al., 1994), only a single
band was detected for HeLa RanGAP1. Moreover, the identity to the 11.5-kDa protein; human SMT3 (Mannen
et al., 1996), with 16% identity to ubiquitin and 47%only band obtained by hybridization with the EST frag-
ment was similar to the size of the longest EST clone identity to the 11.5-kDa protein; and S. cerevisiae SMT3
(Meluh and Koshland, 1995; GenBank accession num-(1.42 kb). These data indicate that the RanGAP1 se-
quence and the 90-kDa protein–specific sequence are ber U27233), with 16% identity to ubiquitin and 52%
identity to the11.5-kDa protein. While the level of identityencoded by two separate mRNAs, implying that the 90-
kDa band observed after immunoprecipitation and SDS– among the ubiquitin/11.5-kDa, ubiquitin/SMT3, and
Nedd8/11.5-kDa pairs is very low, sequence alignmentPAGE contains a stable complex between the 70-kDa
RanGAP1 and the putative 11.5-kDa protein. clearly revealed that these proteins are related. Of the
76 amino acid residues in ubiquitin, 32 (42%) are eitherUsing the basic local alignment search tool (BLAST)
algorithm, we found that this protein (and a partially identical or highly conserved in all proteins (Figure 3C,
Ubiquitin-Related Modification of RanGAP1
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consensus). Since the 11.5-kDa protein is functionally
related to ubiquitin (see below), we have named it small
ubiquitin-related modifier (SUMO-1).
SUMO-1 Converts the 70-kDa RanGAP1
to a 90-kDa Protein
The homology of the 11.5-kDa SUMO-1 to ubiquitin sug-
gested that it might be involved in converting the 70-kDa
RanGAP1 to the 90-kDa form through a posttranslational
covalent modification. To address this question, we
used affinity-purified aSUMO-1 antibodies in Western
blot analysis of nuclear fractions (Figure 4A) and in im-
munoprecipitates of RanGAP1 from solubilized NEs
(Figure 4B). SUMO-1 antibodies strongly react with 90-
kDa RanGAP1 but not with 70-kDa RanGAP1, support-
ing the idea that 90-kDa RanGAP1 is modified with
SUMO-1. Interestingly, while 90-kDa RanGAP1 is the
major immunoreactive band in nuclei, aSUMO-1 anti-
bodies detected three additional nuclear proteins with
molecular masses of z120 kDa and 140–150 kDa that
are specifically enriched in the nuclear content fraction
(Figure 4A, DNase supernatant).
Ubiquitination is accomplished by an ATP-dependent
process (reviewed by Ciechanover, 1994; Hochstrasser,
1995) and can be achieved in vitro because cells contain
an excess of the ubiquitin moiety. To determine whether
SUMO-1 modification of RanGAP1 showed similar char-
acteristics, we incubated recombinant RanGAP1 with a
Figure 4. The 90-kDa RanGAP1 Is Formed by Covalent Modification
HeLa cell extract that had either been preincubated with of 70-kDa RanGAP1 with SUMO-1
ATP or depleted of ATP. Figure 4C shows that the 70-
(A) Antibodies raised against SUMO-1 react with a 90-kDa band in
kDa recombinant RanGAP1 was shifted in a time-depen- rat liver nuclei.Antibodies raised against recombinant SUMO-1 were
dent fashion to a 90-kDa band in the cell extract con- used to probe rat liver nuclear fractions. Nuclei, DNase supernatant,
taining ATP. This reaction was extremely rapid, as a and NEs were prepared as before (see Figure 2A) and subjected to
immunoblotting. aSUMO-1 antibodies react with a 90-kDa band andsignificant fraction of the protein was already converted
with three additional bands (open arrows) that are released with the10 s after mixing. Conversion was ATP dependent, as
contents of nuclei (DNase Sup).pretreatment of the cell extract with hexokinase–
(B) Immunoprecipitated 90-kDa RanGAP1 contains SUMO-1. NEs
glucose (Figure 4C, minus ATP) prevented the shift al- were solubilized and incubated with aRanGAP1 antibodies pread-
most completely. The apparent 20-kDa size shift is con- sorbed to Protein A beads. Antibody–antigen complexes were sepa-
sistent with the addition of one SUMO-1 per RanGAP1, rated on a 5%–15% gradientgel and immunoblotted with aRanGAP1
and aSUMO-1 antibodies. Asterisk, IgG heavy chain.as recombinant SUMO-1 itself migrates with an appar-
(C) Recombinant 70-kDa RanGAP1 can be shifted to the 90-kDaent molecular mass of 17 kDa, both on SDS–PAGE and
form in an ATP-dependent manner. HeLa cells were permeabilizedby molecular sieving (data not shown). Moreover, when
with digitonin and preincubated for 30 min at room temperature
GST–SUMO-1 (43 kDa) was added to the in vitro shift with 1 mM ATP (plus ATP) or with hexokinase and glucose (minus
assay, some RanGAP1 was shifted to an apparent mass ATP). Recombinant RanGAP1 was added and incubated at room
of z110 kDa, consistent with the addition of one GST– temperature, and samples were mixed with SDS loading buffer at
times indicated. Proteins were analyzed by immunoblotting withSUMO-1 (data not shown). Western blot analysis with
aRanGAP1 antibodies.aSUMO-1 antibodies on a 1:1 mixture of 70- and 90-
(D) In vitro generated 90-kDa RanGAP1 contains SUMO-1. A mixturekDa proteinprepared byincubation of recombinant Ran-
of 70-kDa and 90-kDa RanGAP1 was prepared as described in Ex-
GAP1 with HeLa extracts (Figure 4D) showed specific perimental Procedures and analyzed by immunoblotting with aRan-
reaction with the 90-kDa band, but not with the 70- GAP1 and aSUMO-1 antibodies.
kDa species, demonstrating that the 90-kDa RanGAP1
contained SUMO-1.
RL1, aRanGAP1 also stained the cytoplasm. The same
staining pattern was obtained with aGAP-tail antibodiesRanGAP1 Is Localized Predominantly at the NPC
To localize the 70/90-kDa RanGAP1, we analyzed nor- (data not shown). Cytoplasmic staining was lost when
cells were permeabilized with digitonin prior to fixationmal rat kidney (NRK) cells by double immunofluores-
cence staining with aRanGAP1 antibodies and with the (data not shown), indicating that the cytoplasmic pool
of RanGAP1 is soluble. Confocal images of the cellsNPC-specific RL1 monoclonal antibodies, which recog-
nize a family of O-linked glycoproteins of the NPC (Snow (Figure 5B) showed nuclear rim staining in an equatorial
view and punctate labeling in a nuclear surface view.et al., 1987). Immunofluorescence microscopy (Figure
5A) showed that like RL1, aRanGAP1 antibodies deco- This is virtually identical to the pattern of RL1 staining
and suggests localization of RanGAP1 to NPCs. Therate predominantly the NE. However, in contrast with
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Immunogold labeling of isolated rat liver NEs with
aRanGAP1 antibodies (Figure 5C) resulted in the exclu-
sive decoration of the cytoplasmic surface of the NE,
specifically at NPCs. Most of the labeling was found in
peripheral regions of the NPC, at a distance of 52 (6
14) nm (n = 101) from a plane bisecting the NPC into
nucleoplasmic and cytoplasmic halves. This is very simi-
lar to the localization of the Ran-GTP-binding site at the
NPC (Melchior et al., 1995a) and to the localization of
RanBP2/Nup358 (Wu et al., 1995; Yokoyama et al.,
1995), which is the putative site of initial substrate bind-
ing during nuclear import.
The 90-kDa SUMO-1–RanGAP1 Conjugate
but Not 70-kDa RanGAP1 Stably Interacts
with RanBP2
The similar localizations of RanGAP1 and RanBP2 at
the cytoplasmic periphery of the NPC, and the presence
of a >300-kDa protein in the immunoprecipitate of Ran-
GAP1 from NEs (see Figure 2C, Coomassie P), sug-
gested that RanGAP1 might be associated in vivo with
the 358-kDa RanBP2. To address this possibility, we
investigated whether these two polypeptides could be
coimmunoprecipitated from samples of NEs solubilized
in RIPA buffer by aRanGAP1 and aRanBP2 antibodies.
Figure 6A shows that both aRanGAP1 and aRanBP2
antibodies precipitate the 90-kDa RanGAP1–SUMO-1
conjugate and RanBP2. This demonstrates that RanBP2
is indeed present in a stable complex with RanGAP1.
Interestingly, this stable association seems to be spe-
cific for the 90-kDa modified RanGAP1 species, since
aRanBP2 antibodies failed to precipitate the 70-kDa un-
conjugated form of RanGAP1, even though a significant
amount of 70-kDa protein was generated upon solubili-
zation of the envelopes (Figure 6A, right; compare S and
P). This suggests that the interaction between RanGAP1
and RanBP2 involves the SUMO-1 modification. This
interaction is likely to be direct, as no additional specific
bands could be detected in the aRanGAP1 immunopre-
cipitate (Figure 6A, Coomassie). Additional proteins
present in the aRanBP2 immunoprecipitate are mostFigure 5. RanGAP1 Is Localized at the Cytoplasmic Surface of the
likely proteolytic fragments of RanBP2, since this proteinNPC
is extremely sensitive to proteolysis (Bischoff et al.,(A) Detection of RanGAP1 in NRK cells by immunofluorescence
microscopy. Cells were double stained with aRanGAP1 (left) and 1995b, Melchior et al., 1995).
RL1 (right) and analyzed by light microscopy. To investigate directly whether SUMO-1 modulates
(B) Detection of RanGAP1 by confocal immunofluorescence micros- the binding to RanBP2, we carried out in vitro binding
copy of NRK cells. Cells were double stained with aRanGAP1 (top assays with modified and unmodified RanGAP1. We pre-
panels) and RL1 (bottom panels). Single sections through the equa-
pared a 1:1 mixture of these proteins by incubating re-torial plane (left) or nuclear surface plane (right) are shown.
combinant RanGAP1 with digitonin cytosol and ATP un-(C) Immunogold localization of RanGAP1 in isolated rat liver NEs.
der conditions in which only 50% of the protein wasShown are thin section electron micrographs of isolated rat liver
NEs displaying NPCs either in cross sections (A–E) or in tangential shifted to the 90-kDa species (as shown in Figure 4C,
sections (F–H). Note that gold particles are found exclusively at all recombinant RanGAP1 is competent to be shifted).
the cytoplasmic side of NPCs (arrowheads). Cytoplasmic (C) and To ensure stability of both forms and to rule out indirect
nuclear (N) faces of the NEs are easily distinguished by the presence binding via other cytosolic components, the RanGAP1
of residual chromatin (ch) on the nucleoplasmic side.
proteins were partially purified by ion exchange chroma-Scale bar, 100 nm.
tography followed by molecular sieving. As shown by
silver staining (Figure 6B, 70/90 mix), only a few addi-
absence of cytoplasmic staining in optical sections ob- tional proteins are present in the final 70/90 mixture.
tained with confocal microscopy suggests that the cyto- These proteins are unlikely to interact with RanGAP1,
plasmic concentration of RanGAP1 is significantly lower as they elute in different peak fractions from the 90-
than the concentration at the NE. This interpretation is kDa RanGAP1. Moreover, the 70-kDa and the 90-kDa
consistent with the biochemical fractionation of rat liver, RanGAP1 elute very close together, and the 70-kDa pro-
which revealed a strong enrichment of RanGAP1 in NEs tein in the 70/90 mix elutes in exactly the same position
as untreated recombinant RanGAP1 (data not shown).(at least 100-fold over SN1; see Figure 2A).
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Figure 7. NE-Associated RanGAP1 Is Required for Nuclear Protein
Import
(A) Complete transport reactions were incubated in the presence
(3–5) or absence (1–2) of a final concentration of 0.5 mg/ml aRan-
GAP1 antibodies for 30 min at 48C before initiation of nuclear protein
import at 308C. Lane 1, normal transport. Lane 2, ice control. Lane
3, antibody-inhibited transport. Lane 4, addition of 50 mg/ml Ran-
GDP to antibody-inhibited transport. Lane 5, antibodies preincu-
bated (asterisk) with recombinant RanGAP (50 mg/ml final concen-
tration in the transport assay) for 15 min demonstrate specificity of
the inhibition.
(B) Digitonin-permeabilized HeLa cells were incubated for 1 hr onFigure 6. The 90 kDa Modified Form of RanGAP1 Is Stably Associ-
ice in the presence (lanes 7, 9, 11, 12) or absence (lanes 6, 8, 10)ated with RanBP2
of 0.5 mg/ml aRanGAP1 antibodies. Unbound antibodies were re-
(A) Immunoprecipitation from solubilized NEs using both aRanGAP1 moved, and cytosol, substrate, and ATP-regenerating system were
and aRanBP2 antibodies was carried out as in Figure 2C. A control added before initiating nuclear protein import at 308C. Lanes 8 and
reaction with Protein A–Sepharose beads alone (no antibody) was 9, addition of 2 mg/ml recombinant RanGAP1 to the transport mix.
carried out in parallel. Immunoprecipitates were resolved on a 5%– Lanes 10 and 11, addition of 10 mg/ml recombinant RanGAP1. Lane
15% gradient SDS gel and analyzed by Coomassie blue staining 12, antibodies preincubated (asterisk) with recombinant RanGAP
(left) and blot overlay analysis with [32P]GTP–Ran to identify RanBP2 (50 mg/ml final concentration on the permeabilized cells) for 15 min
(middle). Distribution of the 70-kDa and 90-kDaRanGAP1 was deter- prior to addition to the permeabilized cells demonstrate specificity
mined by immunoblotting of supernatants (S) and pellets (P) with of the inhibition. Mean values are shown; error bars indicate actual
aRanGAP1 antibodies (right). Asterisk, IgG heavy chain. values of duplicate experiments.
(B) RanBP2 and an in vitro generated mixture of 70-kDa and 90-
kDa RanGAP1 were used in the binding assay. RanBP2 was purified
from rat liver NEs, resolved on a 5%–15% SDS gel, and identified
100-fold excess of SUMO-1 (data not shown). The bind-by silver staining. The 70/90 mix of RanGAP1 was generated from
ing of the 70-kDa unmodified RanGAP1 to RanBP2-recombinant RanGAP1 (see Experimental Procedures), and the
components of the partially purified mix were identified by silver coated wells, observed primarily at the highest concen-
staining. tration tested (4.0 mg/ml, equivalent to 60 nM), appeared
(C) The 90-kDa RanGAP1 binds to immobilized RanBP2. The 70/90 to be largely or completely nonspecific, because similar
mix was immunoblotted with aRanGAP1 antibodies to identify the
amounts were also found in the BSA-coated wells.relative ratio of the two forms of RanGAP1 (load). RanBP2 or BSA
immobilized on microtiter wells was incubated with increasing
RanBP2-Associated RanGAP1 Is Requiredamounts of the 70/90 mix. The bound fractions were washed, resus-
pended in SDS gel loading buffer, and analyzed by immunoblotting for Nuclear Protein Import
with aRanGAP1 antibodies (bound). The existence of a cytosolic pool of RanGAP1 (approxi-
mately 30%–40% of the total RanGAP1) raised theques-
tion of whether this pool has a specific role in nuclear
protein import. It has been proposed that Ran-GDP isWe purified the 358-kDa protein RanBP2 from rat liver
to homogeneity by using affinity chromatography fol- required at the cytoplasmic side of the NPC (Nehrbass
and Blobel, 1996). According to this model, RanGAP1lowed by ion-exchange chromatography (Figure 6B,
RanBP2). The purified protein was bound to microtiter might simply be required to recycle Ran-GDP. In this
case, exogenously added Ran-GDP would be expectedwells and incubated with increasing concentrations of
the 70/90-kDa RanGAP1 mixture (0.2 mg/ml to 4.0 mg/ to relieve aRanGAP-mediated inhibition. As shown in
Figure 7A, the addition of 50 mg/ml Ran-GDP had noml, equivalent to 3–60 nM; Figure 6C). After washing,
the bound fraction was solubilized with SDS gel loading effect on antibody-inhibited nuclear protein import.
However, since Ran is readily able to diffuse in andbuffer and analyzed by immunoblotting (Figure 6C,
bound). As a specificity control, the 70/90-kDa mix was out of the nucleus (Melchior et al., 1995), we could not
exclude the possibility that rapid exchange of GTP foralso incubated with BSA-coated microtiter wells. Even
though the 70/90 mix contained more than 50% unmodi- GDP by nuclear RCC1 was reducing the effective con-
centration of exogenous Ran-GDP. To address thisfied RanGAP1 (Figure 6C, load), nearly all of the Ran-
GAP1 that bound to RanBP2 was of the 90-kDa modified question, we performed a second experiment, shown
in Figure 7B, in which only NPC-bound RanGAP1 wasform. This binding was not competed by addition of a
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inhibited by preincubation of permeabilized cells with 1996), and the S. cerevisiae SMT3. No function has yet
been established for these proteins, and we speculatethe antibodies. Antibody-treated cells were washed to
remove unbound antibodies, combined with untreated that they may also function as covalent modifiers.
cytosol or cytosol plus recombinant RanGAP1, and used
for transport assays. This pretreatment of cells led to a Stable Modification of RanGAP1 by SUMO-1
significant (z50%) inhibition of nuclear import, which In contrast with most ubiquitinated proteins, RanGAP1
could not be relieved by addition of either a 10- or a 50- modified by SUMO-1 seems to be metabolically stable.
fold excess of recombinant RanGAP1 over the inhibited No higher molecular mass RanGAP1 conjugates, indica-
NPC-associated RanGAP1. This experiment clearly tive of polyubiquitination and a ubiquitin-mediated deg-
demonstrates that inhibition of import by antibodies to radation pathway, can be detected in intact cells or upon
RanGAP1 is not simply caused by depletion of Ran- in vitro modification. Moreover, the predominant site
GDP or accumulation of Ran-GTP, because recombi- required for assembly of polyubiquitin chains on target
nant RanGAP1 is very effective in converting Ran-GTP proteins, lysine residue 48 in ubiquitin, is absent in
to Ran-GDP (see Figure 1B). The reduced level of inhibi- SUMO-1. These findings suggest that modification of
tion in this case, compared with experiments where high RanGAP1 by SUMO-1 does not target RanGAP1 for deg-
concentrations of antibodies were present throughout radation.
the import reaction (see Figures 1B and 7A), is likely to Modified and unmodified forms of RanGAP1 are likely
be due to dissociation of antibodies during the transport to be present in a dynamic equilibrium in vivo, as inter-
reaction or to limited access of antibodies to RanGAP conversion is possible in vitro (see Figures 2B and 4C).
in the preincubation step. Transport inhibition by aRan- Complete conversion to the 70-kDa form occurs upon
GAP1 antibodies was also observed in reconstituted fractionation of cytosol or high salt extracts of NEs over
assays lacking cytosolic RanGAP1, in which cytosol was molecular sieving columns, presumably owing to sepa-
replaced with recombinant cytosolic factors (Ran-GDP, ration of free SUMO-1 protein (unpublished data). Our
NTF2, p97, and Srp1a). These results indicate that data suggest that both conjugating and cleaving en-
RanBP2-associated RanGAP1 is required for nuclear zymes are present in cell extracts. However, in total cell
import, and that cytosolic RanGAP1 cannot substitute extracts, the modification of RanGAP1 is much more
for this requirement. rapid than its demodification, suggesting that in vivo the
RanGAP1–SUMO-1 conjugate is a long-lived species.
Discussion
SUMO-1 Is Involved in Targeting RanGAP1
to the NPC Protein RanBP2SUMO-1, a Novel Ubiquitin-Related Protein
We found that RanGAP1 is highly concentrated at theWe have identified a novel polypeptide of 101 amino
NPC and forms a stable complex with RanBP2. Threeacids (SUMO-1) that is covalently linked to RanGAP1 in
lines of evidence argue that this interaction requires thean ATP-dependent reaction. SUMO-1 shows a low, but
modification of RanGAP1 with SUMO-1. First, when NEssignificant, homology to ubiquitin, a highly conserved
are solubilized with RIPA buffer and a significant fraction76-residue protein found in eukaryotes that is conju-
of modified RanGAP1 becomes demodified, aRanBP2gated via its C-terminal carboxyl group to lysine e-amino
antibodies coprecipitate only the modified RanGAP1.groups of acceptor proteins (reviewed by Ciechanover,
Second, when NEs are extracted with high salt (condi-1994; Hochstrasser,1995). The ATP-dependant ubiquiti-
tions that do not solubilize a significant amount ofnation reaction, which involves a cascade of enzymatic
RanBP2), modified RanGAP1 distributes evenly be-reactions, is best known for its ability to initiate regulated
tween supernatant and pellet, while 70-kDa RanGAP1protein degradation by a complex called the 26S protea-
is nearly completely soluble. Third, in binding assayssome. Commitment of a target protein to the degrada-
with purified rat liver RanBP2 and a mixture of modifiedtion pathway involves assembly of a polyubiquitin chain
and unmodified RanGAP1, only modified RanGAP1on the target, often via isopeptide bonds between lysine
binds to RanBP2. Taken together, these data indicate48 of one ubiquitin and the C-terminus of the neigh-
that the ubiquitin-related modification of RanGAP1boring ubiquitin (Ciechanover, 1994). However, exam-
serves to target RanGAP1 toRanBP2. Saitohet al. (1996)ples of metabolically stable ubiquitin conjugates con-
recently reported that an 88-kDa protein that coimmuno-taining a single ubiquitin moiety, such as Ub-histone
precipitates with RanBP2 from a Xenopus laevis eggH2A, have been documented, and it is becoming in-
extract contains peptide sequences found in RanGAP1creasingly evident that the role of the ubiquitin modifica-
as well as some additional unique sequences. It seemstion is not limited to a degradation signal (reviewed by
likely that this 88-kDa protein is in fact modifiedHochstrasser, 1996).
RanGAP1.This theme is extended by the present study, in which
we demonstrate that SUMO-1 is a ubiquitin-related pro-
tein modifier that appears to be involved in protein tar- RanBP2-Associated RanGAP1 Is Required
in Nuclear Protein Importgeting and not degradation. Immunoblot analysis indi-
cates that at least three additional intranuclear proteins Although the requirement for GTP hydrolysis by Ran
during nuclear import is well established, the site of GTPare modified with SUMO-1 or with a protein very closely
related to it. Our database search revealed three pro- hydrolysis has remained a matter of dispute. Models
involving either single (Melchior et al., 1995a) or multipleteins related to ubiquitin, the Nedd8 protein from mouse
(Kumar et al., 1993), the human SMT3 (Mannen et al., sites (Rexach and Blobel, 1995; Nehrbass and Blobel,
Ubiquitin-Related Modification of RanGAP1
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Research Institute. HeLa total RNA was prepared with TriReagent1996; Go¨rlich and Mattaj, 1996) of GTP hydrolysis have
(Molecular Research Center, Incorporated). Northern blot hybridiza-been proposed. The data presented here suggest that
tion was performed according to standard protocols. Radiolabeledthe localization of RanGAP1 at RanBP2 is essential for
probes were generated by using the full-length coding sequence
its function in nuclear protein import, as inhibition of for SUMO-1 or a 1.1 kb fragment of RanGAP1 as templates for
NPC-bound RanGAP1 by antibodies to RanGAP1 leads random priming with the Prime-it II kit (Stratagene).
to an inhibition of nuclear protein import that cannot be
rescued by exogenously added RanGAP1. Furthermore, Expression and Purification of Recombinant Proteins
RanGAP1 was bacterially expressed as described for Ran (Melchiorefficient in vitro import can be reconstituted when cyto-
et al., 1995b). After lysozyme lysis the bacterial pellet was washedsol is replaced with soluble transport factors in the ab-
twice with buffer 1 (Melchior et al., 1995b), 1% Triton X-100, oncesence of soluble RanGAP1 (e.g., Go¨rlich et al., 1995; our
with 2 M urea, 50 mM Tris–HCl (pH 7.4), and solubilized with 8 M
unpublished data). Taken together, these findings show urea. The supernatant was dialyzed against 50 mM Tris–HCl, 100
that cytosolic RanGAP1 is not required for nuclear im- mM NaCl (pH 7.4), centrifuged at 100,000 3 g for 1 hr, applied to a
port, while RanBP2-bound RanGAP1 is essential. This Q–Sepharose column (Pharmacia) that had been washed with 200
mM NaCl, and eluted with 1 M NaCl. Final purification was achievedstrongly suggests that GTP hydrolysis by Ran at RanBP2
by molecular sieving (Superdex 200, Pharmacia) in transport bufferis an essential part of nuclear protein import. Together
(TB; Melchior et al., 1995b). Expression and purification of GST–with our previous finding that Ran accumulates at
GAP-tail, GST–RanBP2, and GST–SUMO-1 fusion proteins followed
RanBP2 when it cannot hydrolyze its GTP (Melchior et standard procedures. Pure SUMO-1 was obtained by thrombin di-
al., 1995), these data support a model in which nuclear gestion of GST-SUMO-1 bound to gluthathione beads and gel filtra-
import involves a single round of Ran-GTP hydrolysis tion of the resulting supernatant. Recombinant Ran/TC4 was ex-
pressed as described by Melchior et al. (1995b).at RanBP2. While we cannot rule out that GTP hydrolysis
by Ran may also occur at other sites, there is currently
Antibodiesno direct evidence to support this, as far as we know.
Rabbits were injected with 500 mg of protein (RanGAP1, GAP-tail,RanBP2 is localized at fibrils emanating from the cyto-
RanBP2, or SUMO-1) emulsified with Titermax (Vaxcel, Incorpo-plasmic peripheryof theNPC (Wu et al., 1995; Yokoyama
rated). Boosts were with 200 mg of protein emulsified with incom-
et al., 1995), which are implicated in initial binding of plete Freund’s adjuvant. Antibodies were affinity purified from serum
transport substrates to the NPC(Pante´ and Aebi,1996b). by adsorption to affinity columns containing recombinant protein
RanBP2 contains Ran-GTP-binding domains as well as and subsequent elution with 0.2 M acetic acid (pH 2.7), 0.5 M NaCl.
RL1 monoclonal antibodies are described by Snow et al. (1987).FG repeat domains, which can interact with a complex
Peroxidase-conjugated goat arabbit immunoglobulin G (IgG) wascontaining NLS receptor, p97, and substrate in vitro
from Pierce, rhodamine-conjugated donkey arabbit IgG and FITC-(e.g., Hu et al., 1996). Several possible functions for Ran-
conjugated goat amouse IgG from Jackson ImmunoResearch, and
GTP and the hydrolysis step can be envisioned. For 5-nm colloidal gold conjugated to goat arabbit IgG from Zymed.
example, the NLS receptor–substrate–p97 complex and
Ran-GTP might initially interact with RanBP2 at the cyto- Preparation of Rat Liver NEs and Immunoprecipitation
plasmic fibrils (Melchior et al., 1995a, Pante´ and Aebi, NEs were prepared as described by Snow et al. (1987). For immuno-
precipitation, NEs were solubilized at an OD260 of 100 in RIPA buffer1996b). After receptor-substrate–p97 and RanGTP have
(50 mM Tris–HCl [pH 8.0], 150 mM NaCl, 1% Nonidet P-40, 0.5%bound to RanBP2, RanGAP1 would stimulate GTP hy-
deoxycholate, 0.1% SDS, 1 mM DTT, 0.1 mM PMSF, 1 mg/ml eachdrolysis by Ran to commit the transport complex to
of leupeptin, pepstatin A, and aprotinin) for 2 hr on ice and centri-
more distal steps of the import pathway. In another fuged at 100,000 3 g for 30 min. Antibodies (10 mg) (aRanGAP1 or
scenario, Ran-GTP might form a complex with p97 in- aRanBP2) prebound to 5 ml of protein A–Sephacryl beads (Pierce)
side the nucleus during disassembly of a transport com- were added to each 100 OD of solubilized NEs and incubated over-
night on ice. After three washes in RIPA buffer, antigen–antibodyplex. The p97–Ran-GTP complex could then exit the
complexes were solubilized in SDS–PAGE loading buffer.nucleus and bind to RanBP2, where RanGAP1-induced
GTP hydrolysis would release Ran-GDP from the com-
Immunoblotting, Indirect Immunofluorescence,plex and thereby allow RanBP2-bound p97 to interact
and Immunogold Electron Microscopywith a NLS receptor–substrate complex. In any case,
Detection of RanGAP1 on immunoblots was performed with 0.5
the datapresented here strongly favor models of nuclear
mg/ml aRanGAP1 or aGAP-tail, 5 mg/ml aSUMO-1, and 1 mg/ml
protein import in which the localization of RanGAP1 at aRanBP2 antibodies in 5% milk powder in PBS, 0.2% Tween 20 for
the cytoplasmic periphery of the NPC imparts vectori- 1 hr at room temperature. Detection was by enhanced chemilumi-
nescence (Amersham).ality to the import pathway.
For indirect immunofluorescence using light or confocal micros-
copy, NRK cells were fixed on coverslips with 3.7% formaldehydeExperimental Procedures
in PBS and processed as described by Melchior et al. (1995b).
Antibodies were used at 0.5 mg/ml (aRanGAP1) and at a 1:200 dilu-DNA Cloning and Northern Blot Hybridization
tion (RL1 ascites fluid). For immunogold electron microscopy, ratRanGAP1 cDNA obtained by reverse transcription of NIH 3T3 mRNA
liver NEs (200 OD260 /ml) were incubated with 10 mg/ml aRanGAP1and subsequent polymerase chain reaction (PCR) was cloned into
in PBS/Mg, 0.5% BSA for 2 hr at room temperature, and processedthe pET-11d vector (Novagen). Amino acids 400–589 of the coding
as described by Melchior et al. (1995a).sequence were cloned into the pGEX-2T plasmid (Pharmacia) to
create a GST–GAP-tail fusion protein, and amino acids 1592–1766
of RanBP2 were cloned into pGEX-2T to create a GST–RanBP2 Blot Overlay and GAP Assays
Recombinant Ran was loaded with [a-32P]GTP and blot overlaysfusion protein. A cDNA fragment encoding the ORF of SUMO-1 was
obtained by PCR from the I. M. A. G. E. Consortium cDNA clone with [a-32P]Ran-GTP were carried out as described by Melchior et
al. (1995a). GAP assays were initiated by adding 2 ml of [a-32P]Ran-number 49768 and was cloned into pGEX-2T to create a GST–
SUMO-1 fusion protein. I. M. A. G. E. Consortium cDNA clones GTP (40 mg/ml final concentration) to 8 ml of recombinant RanGAP1
(1 mg/ml final concentration) in TB in the absence or presence of(numbers 49768, 51818, and 199507; Lennon et al., 1996), containing
the SUMO-1 ORF, were sequenced at the core facility of The Scripps 20 mg/ml aRanGAP1 or 100 mg/ml of aGAP-tail antibodies. At the
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times indicated, 1-ml samples were spotted onto cellulose polyethyl- (1995a). Human RanGTPase-activating protein RanGAP1 is a homo-
logue of yeast Rna1p involved in mRNA processing and transport.eneimine thin-layer chromatography plates (J. T. Baker) and chro-
matographed in 1.0 M formic acid, 0.5 M LiCl. Amounts of GTP and Proc. Natl. Acad. Sci. USA 92, 1749–1753.
GDP were determined with a Phosphorimager (Molecular Dynam- Bischoff, F.R., Krebber, H., Smirnova, E., Dong, W., and Ponstingl,
ics), and percent GTP was calculated. H. (1995b).Co-activation of RanGTPase and inhibition of GTP disso-
ciation by Ran–GTP binding protein RanBP1. EMBO J. 14, 705–715.
Nuclear Import Assays and In Vitro Modification of RanGAP1 Bourne, H.R., Sanders, D.A., and McCormick, F. (1990). The GTPase
In vitro nuclear import into HeLa cells followed protocols described superfamily: a conserved switch for diverse cell functions. Nature
by Paschal and Gerace (1995). For in vitro modification of RanGAP1, 348, 125–132.
HeLa cells were permeabilized with digitonin at 4 3 107 cells/ml and Ciechanover, A. (1994). The ubiquitin–proteasome proteolytic path-
with 0.07% digitonin. ATP (1 mM) or 400 U/ml hexokinase plus 5 way. Cell 79, 13–21.
mM glucose (to deplete cellular ATP) were added to the cell lysate,
Corbett, A.H., Koepp, D.M., Schlenstedt, G., Lee, M.S., Hopper, A.K.,which was then incubated 30 min on ice. Reactions received 4 mg/
and Silver, P.A. (1995). Rna1p, a Ran/TC4 GTPase activating protein,ml recombinant RanGAP1, were incubated at room temperature,
is required for nuclear import. J. Cell Biol. 130, 1017–1026.and were quenched by the addition of 23 SDS loading buffer.
Dasso, M., Seki, T., Ohba, T., and Nishimoto, T. (1994). A mutantA 1:1 mixture of 70-kDa and 90-kDa RanGAP1 was prepared by
form of the Ran/TC4 protein disrupts nuclear function in Xenopusincubating 50 mg of recombinant RanGAP1 for 10 min at room tem-
laevis egg extracts by inhibiting the RCC1 protein, a regulator ofperature in 1.8 ml of digitonin supernatant (from a 200 3 g, 5-min
chromosome condensation. EMBO J. 13, 5732–5744.supernatant of 7 3 107 cells) and ATP. The mixture was diluted 10-
fold with ice-cold TB, 300 mM NaCl, incubated with Q–Sepharose DeGregori, J., Russ, A., von Melchner, H., Rayburn, H., Priyaranjan,
beads, washed, and eluted with 1 M NaCl in TB. The 70/90-kDa mix P., Jenkins, N.A., Copeland, N.G., and Ruley, H.E. (1994). A murine
was further purified by gel filtration (S200-FPLC, Pharmacia). The homolog of the yeast RNA1 gene is required for postimplantation
70- and 90-kDa RanGAP1 eluted at an apparent molecular mass of development. Genes Dev. 8, 265–276.
z120 kDa, similar to the behavior of pure recombinant RanGAP1 Floer, M., and Blobel, G. (1996). The nuclear transport factor kary-
(unpublished data) and RanGAP1 purified from HeLa cells (Bischoff opherin beta binds stoichiometrically to Ran–GTP and inhibits the
et al., 1994). Ran GTPase activating protein. J. Biol. Chem. 271, 5313–5316.
Go¨rlich, D., and Mattaj, I.W. (1996). Nucleocytoplasmic transport.
Binding Assay Science 271, 1513–1518.
The 358 kDa RanBP2 was purified from rat liver NEs by Ran-affinity Go¨rlich, D., Vogel, F., Mille, A.D., Hartmann, E., and Laskey, R.A.
chromatography (adapted from protocols described by Saitoh and (1995). Distinct functions for the two importin subunits in nuclear
Dasso [1995]) and a Mono Q FPLC column. Microtiter plates were protein import. Nature 377, 246–248.
coated with 20 ng of RanBP2 per well and blocked overnight with
Hochstrasser, M. (1995). Ubiquitin, proteasomes, and the regulation3% BSA, 0.05% Tween 20 in PBS. After washing with TB, 0.05%
of intracellular protein degradation. Curr. Opin. Cell Biol. 7, 215–223.Tween 20, 2% BSA, increasing concentrations of the 70/90 Ran-
Hochstrasser, M. (1996). Protein degradation or regulation: Ub theGAP1 mixture were added and incubated at room temperature for 1
judge. Cell 84, 813–815.hr. The wells were washed four times and extracted with SDS–PAGE
loading buffer. Samples were analyzed by immunoblotting with Hopper, A.K., Traglia, H.M., and Dunst, R.W. (1990). The yeast RNA1
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